Product Offerings
Products:
Poultry: Medivac AE-POX, Medivac ND Clone-45, Medivac Gumboro A
Companion Animal: NA
Swine: NA
Ruminant: NA
Game Fowl: NA
Bird: NA
About Artha Vena International Pte. Ltd.
Artha Vena International Pte. Ltd. is a Singapore-based distributor and wholesaler specializing in animal health solutions, particularly in the poultry sector. The company has built a reputation for delivering high-quality veterinary pharmaceuticals and vaccines that enhance disease prevention and livestock productivity.
With a strong distribution network across Asia, Artha Vena International provides innovative and science-backed veterinary products to poultry farmers, integrators, and veterinarians.
Core Business and Specialization
Artha Vena International focuses on veterinary pharmaceuticals and poultry vaccines, ensuring effective disease control and biosecurity solutions.
Key Areas of Expertise:
- Poultry Vaccines – Advanced immunization solutions to prevent avian diseases.
- Veterinary Pharmaceuticals – Targeted treatments for poultry health.
- Animal Health Distribution – Sourcing and supplying high-quality veterinary products.
Product Portfolio
1. Poultry Vaccines
- Medivac AE-POX – Protects against Avian Encephalomyelitis and Fowl Pox.
- Medivac ND Clone-45 – Newcastle disease prevention with high efficacy.
- Medivac Gumboro A – Immunization against Infectious Bursal Disease (IBD).
Market Presence and Global Reach
Artha Vena International Pte. Ltd. operates in key Asian markets, supplying veterinary professionals, poultry farms, and integrators with high-quality immunization and disease prevention solutions.
Shipment Data:
- Over 2 million doses of poultry vaccines distributed annually.
- Presence in Singapore, Indonesia, Malaysia, and Southeast Asia.
- Major customers include poultry integrators and veterinary suppliers.
Certifications and Compliance
Artha Vena International adheres to strict international quality and safety regulations, ensuring consistent supply chain reliability.
Certifications:
- GMP Certified – Good Manufacturing Practices for vaccine production.
- ISO 9001:2015 – Quality management certification.
- HACCP Compliance – Hazard analysis for veterinary pharmaceutical safety.
- Singapore AVA (Agri-Food & Veterinary Authority) Approved – Ensuring regulatory compliance.
The company partners with globally recognized veterinary pharmaceutical manufacturers to ensure product efficacy and safety.
Research & Development
Artha Vena International collaborates with leading veterinary research institutions to stay at the forefront of poultry disease management and immunization technologies.
Recent R&D Achievements:
- Enhancement of Newcastle Disease vaccine formulations for improved strain protection.
- Innovative immunization strategies to reduce early-stage poultry mortality.
- Advanced storage and logistics solutions for maintaining vaccine efficacy.
Financial Performance
Artha Vena International has seen consistent revenue growth, driven by increasing demand for poultry health solutions. The company’s annual revenue exceeds USD 10 million, with a CAGR (Compound Annual Growth Rate) of 12% over the past five years.
Revenue Breakdown:
- Poultry Vaccines – 80%
- Veterinary Pharmaceuticals – 20%
Key Achievements
- Expanded vaccine distribution to Southeast Asian markets.
- Partnered with leading poultry integrators for large-scale immunization programs.
- Developed a strong reputation for high-quality vaccine sourcing and supply chain management.
- Recognized for contributions to poultry disease prevention in the region.
Target Market and Customer Segments
Artha Vena International serves a wide range of stakeholders in the poultry industry, including:
- Poultry Farmers & Integrators – Large-scale immunization and disease prevention.
- Veterinary Suppliers & Distributors – Wholesale vaccine and pharmaceutical sourcing.
- Government & Regulatory Agencies – Support for national poultry health programs.
- Veterinary Research Institutions – Collaborations for disease prevention strategies.
Conclusion
With its strong expertise in poultry health, reliable distribution network, and commitment to vaccine efficacy, Artha Vena International Pte. Ltd. continues to be a trusted partner in poultry disease prevention and veterinary pharmaceuticals. The company’s dedication to innovation, quality, and market expansion ensures sustained growth and industry leadership in Southeast Asia.